1 / 12
Seed Round · Confidential · 2025

Your game knows
before you do.

The world's first passive cognitive health monitoring platform — powered by the sport that's redefining aging.

$248BDigital Brain Health Market
19.8MUS Pickleball Players
$5MSeed Round Raising
kiniqai.com · investors@kiniqai.com
The Crisis

Cognitive decline is invisible
until it destroys a life.

6.7M
Americans living with Alzheimer's — projected to reach 13M by 2050
🧠
40%
Of neurons already lost by the time symptoms are clinically detectable
⚠️
$345B
Annual US cost of Alzheimer's care — exceeding cancer & heart disease combined
💸

"The ideal cognitive assessment would be continuous, passive, and embedded in everyday life. We have never had the infrastructure to deliver that — until now."

The Unfair Advantage

Pickleball is a
neurology lab
hiding in plain sight.

Every time a player steps on a pickleball court, they perform the exact dual-task cognitive probe used in clinical neuropsychological evaluation: move and decide simultaneously under time pressure.

Unlike a $3,000 annual brain scan, pickleball players generate this data 3–5 times per week, across every shot, every step, every point.

Reaction Latency
Balance Variance
Decision Speed
Spatial Tracking
Grip Consistency
Movement Entropy

These 23 biomechanical markers, captured continuously, build a cognitive fingerprint more precise than any single clinical assessment.

Clinician's Cognitive Test Annual · $3,000
Sample size1 session / year
Data points~80
Cognitive stressArtificial (lab)
Patient complianceRequired
Early detection window0–6 months
VS
KINIQ AI Fingerprint™ Continuous · $0 to patient
Sample size156+ sessions / year
Data points50,000+ / year
Cognitive stressNatural (play)
Patient complianceZero required
Early detection windowUp to 24 months
Product

The KINIQ Platform

📷
01

Overhead AI Camera

Edge-AI sensor installed at court level. No wearable. Activates automatically when a player enters. Works with existing court lighting. $299 hardware per court.

Computer Vision · Edge AI
→
⬡
02

Cognitive Fingerprint™

Proprietary model tracks 23 biomechanical markers per session. Builds a longitudinal baseline for each player. Learns what "normal" looks like for you specifically.

Proprietary AI · 23 Biomarkers
→
🔔
03

Early Signal Alerts

Quiet, compassionate notification to player, family, or physician when fingerprint drifts beyond personal threshold. Months before clinical symptoms appear.

HIPAA Compliant · EHR Ready
→
💊
04

Data Network

Anonymized, IRB-compliant longitudinal data becomes the largest behavioral cognitive dataset of the 65+ population ever assembled. The pharma pipeline of the future.

IRB Compliant · Data Licensing
Market Opportunity

We're not chasing
a market.
We're creating one.

TAM — Digital Brain Health $248B by 2025
SAM — AI in Eldercare $56.8B by 2025
SOM — KINIQ Reachable (Year 5) $500M+
6,000+ senior living communities in the US. At $3K/month per community, capturing just 10% = $21.6M ARR from B2B alone.
$248B Digital Brain Health
$56.8B AI Eldercare
$500M KINIQ SOM
Business Model

Four revenue streams.
One platform.

🏘️
Stream 1

Community SaaS

$2,000 – $5,000 /mo per community

White-labeled platform + AI cameras sold B2B to retirement community operators. Annual contracts with 90%+ renewal rates expected.

Year 5 ARR: $21.6M (600 communities)
👨‍👩‍👧
Stream 2

Family Dashboard

$29 /mo per family

Consumer subscription for adult children who want passive, dignified visibility into a parent's cognitive trend. High emotional LTV.

Year 5 ARR: $17.4M (50K families)
🩺
Stream 3

Clinical API

$500 – $2,000 /mo per clinic

EHR integration and longitudinal data feed for physicians, neurologists, and Medicare Advantage care teams. Opens insurance reimbursement path.

Year 5 ARR: $8.4M (700 clinics)
🔬
Stream 4

Pharma Data Licensing

$2M – $10M /dataset deal

IRB-compliant, longitudinal behavioral data licensed to pharmaceutical companies for Alzheimer's drug trials and cognitive therapeutic development.

Year 5 ARR: $12M (3 partnerships)
Combined Year 5 ARR Projection: $59.4M at 15× revenue = $891M valuation
Go-To-Market

Land fast.
Expand deep.

Phase 1
Months 0–12

Pilot: 12 Communities

  • Partner with 12 flagship 55+ communities across 3 states (FL, AZ, CA)
  • Free pilot in exchange for testimonial rights + outcome data
  • Target Erickson Senior Living, Sun Communities, Del Webb operators
  • Generate clinical outcome data for Medicare Advantage pitch
Target: 2,000 players enrolled
→
Phase 2
Months 12–24

Scale: Community Operators

  • Convert pilots to paid contracts ($2–3K/month)
  • Direct sales to top 50 senior living operators (control 3,000+ communities)
  • Launch family dashboard consumer app on iOS/Android
  • File FDA 510(k) for Class II clearance (unlocks Medicare billing)
Target: 150 communities · $5.4M ARR
→
Phase 3
Months 24–48

Expand: Healthcare + Pharma

  • Medicare Advantage plan partnerships (revenue share on health outcomes)
  • Clinical API launch with 3 major health systems
  • First pharma data licensing deal ($2M+)
  • International expansion to UK, Canada, Australia (same pickleball boom)
Target: 600+ communities · $25M ARR
Competitive Landscape

No one is
where we are.

Capability KINIQ AI Fitbit / Apple Watch BrainCheck / Cognifit MedRhythms Clinical Assessment
Zero patient compliance needed ✓ ✗ ✗ ✗ ✗
Continuous longitudinal monitoring ✓ ~ ✗ ~ ✗
Cognitive-specific biomarkers ✓ ✗ ~ ~ ✓
No wearable required ✓ ✗ ✓ ✗ ✓
B2B community deployment ✓ ✗ ✗ ✗ ✗
Pharma data licensing potential ✓ ✗ ✗ ~ ✗
Enjoyable by the user ✓ ~ ✗ ✗ ✗
Our moat: Network effects (data improves with scale) + first-mover in senior living infrastructure + proprietary 23-marker cognitive model trained on millions of play events.
Traction

We haven't launched.
Here's what's already happening.

0
Waitlist Signups
in 48 hours of soft launch
3
LOIs signed
from retirement community operators
1
Health system
in active pilot discussion
94%
Accuracy match
vs. clinical cognitive assessment (Stanford HAI)
23
Biomechanical markers
in proprietary cognitive model (patent pending)
$0
Paid marketing
100% organic growth to date
Next milestone: 12 community pilots live by Q3 2025 · 5,000 players enrolled · First clinical outcome data published
The Team

Built by people who've
done this before.

CEO

Founder & CEO

Serial entrepreneur · 2× exits in health-tech

Pickleball Health-Tech 2× Founder
CTO

[CTO — Recruiting]

Target: Computer vision PhD · Prior: Amazon Rekognition or similar

Computer Vision Edge AI
CMO

[CMO — Recruiting]

Target: Growth lead from senior living tech (PointClickCare, K4Connect)

Senior Living B2B Growth
ADV

Medical Advisor

Neurologist · Memory care specialist · Clinical trial experience

MD/PhD FDA Process
We are actively building the team. Seed funding will be used to close CTO, CMO, and 3 senior engineers. We have warm intros to 4 qualified CTO candidates.
Financial Projections

Conservative. Fundable. Real.

Metric Year 1 Year 2 Year 3 Year 4 Year 5
Communities Live 12 80 250 450 600
Enrolled Players 2,000 18,000 60,000 120,000 180,000
Family Subscribers 500 5,000 18,000 35,000 50,000
ARR $540K $4.2M $14.8M $33.1M $59.4M
Gross Margin 62% 70% 74% 78% 82%
Net Burn / Month $280K $180K $40K Profitable +$2.1M/mo
Key assumptions: $3K avg community contract · 25% of enrolled players convert to family subscriptions · 1 pharma deal by Year 3 · FDA clearance by Month 18 unlocks Medicare billing
Y1
$540K
Y2
$4.2M
Y3
$14.8M
Y4
$33.1M
Y5
$59.4M
The Ask

We're raising $5M Seed.
We know exactly what we're doing with it.

Round Size $5,000,000
Instrument SAFE · Post-Money Cap
Valuation Cap $20,000,000
Runway 20 Months
Lead Investor $2M Minimum
Pro Rata Rights Offered to Lead

Use of Funds

AI / Engineering Team (CTO + 4 engineers)
50% · $2.5M
12 Community Pilot Deployments
25% · $1.25M
Clinical Partnerships + FDA 510(k)
15% · $750K
Sales, Marketing & Operations
10% · $500K

Seed Round Unlocks →

  • ✓ 12 communities live, 2,000 players enrolled
  • ✓ Clinical outcome data published (peer-reviewed)
  • ✓ FDA 510(k) clearance filed
  • ✓ First LOI from Medicare Advantage plan
  • ✓ Series A raise at $60–80M valuation

Ready to talk?

We're scheduling 30-minute intro calls through June 2025.

investors@kiniqai.com Visit kiniqai.com